Fatih Goksel
1* 
, Yasemin Guzle Adas
2 1 Department of Radiation Oncology, University of Health Sciences Dr. Abdurrahman Yurtaslan Oncology Research and Training Hospital, Ankara, Turkey
2 Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital Radiation Oncology Department
Abstract
Introduction: The aim of this study was to evaluate the demographic characteristics and
radiotherapy schedules of patients for whom palliative radiotherapy for brain metastasis was administered.
Methods: This was a retrospective study that evaluated the patients who received palliative radiotherapy for brain metastases between January 2011 and December 2019. Patient treatment files and the hospital information management system were used to collect the data.
Results: In this study, 4107 patients who received radiotherapy for any brain tumors were
evaluated. Of these, 2910 had metastatic brain tumors. In the metastatic group 1736 (60%) patients were male and 1174 (40%) were female. Primary diagnosis was lung cancer (38%), breast cancer (20%), primary unknown (15%), gastrointestinal cancers (12%), and other cancers (15%). 1643 (52%) patients received whole-brain radiotherapy (WBRT), 535 (18%) received WBRT with stereotactic radiosurgery (SRS) and 706 (29%) received SRS without WBRT for brain metastasis. Radiotherapy data of 26 (1%) patients could not be accessed.
Conclusion: Both WBRT and SRS are good palliative treatment options for brain metastasis. SRS without WBRT can be considered as a treatment option in selected cases.